And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Once again, our agenda is rather modest. We plan to promenade with the official mascot, catch up on our reading, enjoy an overdue listening party and, of course, take a few naps. And what about you? For many, ’tis the season for holiday shopping, supply chain issues notwithstanding. You could winterize your castle. Or pass along a public service announcement about getting vaccinated. Well, whatever you do, have a grand time. But be safe — wear a mask. Enjoy, and see you soon. …
Anthony Fauci is not convinced Covid-19 vaccine manufacturers are going to need to produce an Omicron-specific version of their vaccines, STAT reports. Rather, the long-time director of the National Institutes of Allergy and Infectious Diseases suggested it is possible the current vaccines will provide enough protection against the new variant for most vaccinated and boosted individuals. Fauci stressed that he was hypothesizing, based on how the vaccines have held up against other SARS-CoV-2 variants. Studies will need to be done, he insisted, and manufacturers are working on and will test versions of their vaccines based on the mutation-studded Omicron spike protein. Unlock this article by subscribing to STAT+ and enjoy your first 30 days free! GET STARTED STAT+ is STAT’s premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond. What’s included? Daily reporting and analysis The most comprehensive industry coverage from a powerhouse team of reporters Subscriber-only newsletters Daily newsletters to brief you on the most important industry news of the day STAT+ Conversations Weekly opportunities to engage with our reporters and leading industry experts in live video conversations Exclusive industry events Premium access to subscriber-only networking events around the country The best reporters in the industry The most trusted and well-connected newsroom in the health care industry And much more Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr. This name will appear with your comment
https://www.statnews.com/pharmalot/2021/12/10/covid19-vaccine-omicron-fauci-jnj-opioids/
